General Description
Aminohippurate sodium (para-aminohippurate or PAH) is an organic anion used to measure effective renal plasma flow (ERPF) and to assess tubular secretion function. It is administered intravenously as a continuous infusion or as a bolus. The drug is also known as PAH and has been a classic renal physiology tool for decades.
Mechanism of Action
PAH is freely filtered at the glomerulus and actively secreted into the proximal tubule by the organic anion transporter (OAT) system. At low plasma concentrations, nearly all PAH delivered to the kidney is excreted, such that its clearance approximates total renal plasma flow. The extraction ratio of PAH in healthy kidneys is about 90%, making it the gold standard for ERPF measurement.
Application
Aminohippurate sodium is used to calculate renal plasma flow and to estimate tubular secretory capacity. It is also employed to differentiate between prerenal azotemia and intrinsic renal disease by measuring fractional excretion of PAH.